search
Back to results

Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation

Primary Purpose

Sick Sinus Syndrome, Brady-Tachy Syndrome

Status
Unknown status
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Pacemaker Vitatron Selection 9000
Pacemaker Vitatron T70
Sponsored by
Vitatron France
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sick Sinus Syndrome focused on measuring Pacemaker, Atrial Fibrillation, Prevention pacing, Algorithms, Sick sinus syndrome + Atrial Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient with documented atrial fibrillation: at least one episode of paroxysmal AF documented 6 months prior to inclusion, lasting more than one minute Patient with a brady-tachy syndrome or a sick sinus syndrome, with a permanent pacing indication Atrial lead with a tip-to-ring interval equal to or less than 12 mm Patient who agrees with and has signed the informed consent Exclusion Criteria: Permanent AF AF related to a reversible cause One electrical cardioversion 6 months prior to inclusion Unstable angina Myocardial infarction (MI) less than 3 months Planned cardiac surgery or performed in the last 3 months Congestive heart failure, New York Heart Association (NYHA) class IV Life expectancy less than 18 months Patient participating in other studies Patient not able to follow the FU calendar Less than 18 years of age Pregnancy

Sites / Locations

  • CHGRecruiting
  • Hopital PrivéRecruiting
  • CHRecruiting
  • CHRecruiting
  • Clinique de Bordeaux CauderanRecruiting
  • CHURecruiting
  • CHRecruiting
  • HIA PercyRecruiting
  • CH
  • CH René PlevenRecruiting
  • CHRecruiting
  • CHRecruiting
  • CHRecruiting
  • CHRecruiting
  • CMC Parly IIRecruiting
  • CHRecruiting
  • CHRecruiting
  • CH Saint PhilibertRecruiting
  • Clinique de la CasamanceRecruiting
  • Clinique BouchardRecruiting
  • CHU La TimoneRecruiting
  • CHRecruiting
  • CHRecruiting
  • CHURecruiting
  • CHRecruiting
  • Clinique Ambroise ParéRecruiting
  • Hopital Cardiologique du Haut LevequeRecruiting
  • Hopital Privé Claude GalienRecruiting
  • Polyclinique Saint LaurentRecruiting
  • CHURecruiting
  • CHURecruiting
  • CHURecruiting
  • Institut Arnalt TzanckRecruiting
  • CMCORecruiting
  • CHRecruiting
  • CH ToulonRecruiting
  • CHRecruiting

Outcomes

Primary Outcome Measures

Show clinical benefit of post-AF response and VRS algorithms, when combined versus compared with a control group: In a conventional dual chamber (DDD) configuration
In a configuration including all the preventive pacing therapies of the device
The primary endpoint is the atrial fibrillation burden.

Secondary Outcome Measures

Assess the effect of post-AF response and VRS, when combined versus compared with a control group, in a conventional DDD configuration and another configuration which includes all PPT, on: Number (Nb) of hospitalizations
Nb of cardioversions
Symptom score
Restarts
Daily incidence of AF
Mean sinus rhythm duration
Assess clinical benefit of the overall AF therapies, as compared with the first four algorithms of the previous device (one continuous overdrive +3 triggered overdrive), on the same outcomes as above and AF burden

Full Information

First Posted
September 20, 2005
Last Updated
October 17, 2006
Sponsor
Vitatron France
search

1. Study Identification

Unique Protocol Identification Number
NCT00224341
Brief Title
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
November 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Vitatron France

4. Oversight

5. Study Description

Brief Summary
The objective of this trial is to show the therapeutic efficacy of the preventive pacing therapies of the Selection 9000 and Vitatron T70 DR pacemakers, dedicated to handle atrial fibrillation (AF). Two new algorithms (post-AF response and ventricular rate stabilization [VRS]) will be assessed in a combined pathway, compared to a control group. The efficacy of the overall available therapies to prevent AF and its symptoms will then be assessed also.
Detailed Description
Due to anti-arrhythmic pharmacological drugs failure to suppress atrial fibrillation (AF), interest towards preventive pacing treatments is increasing. The importance of this option in the panoply of the preventive tools is fully justified, only by considering the insufficiency, the complexity, or the poor reproducibility of the other non-pharmaceutical approaches. Preventive pacing therapies rely on their potential effect on different onset modalities emphasized by previous studies, and more generally by stabilizing atrial tissue when potential triggers are appearing. On top of that, cardiac stimulator can deliver these therapies when identifying these triggers but also can offer incomparable diagnostic tools, in terms of sensitivity, specificity and continuity in the monitoring. Four preventive pacing therapies have already been evaluated, the objective of this study is to show the clinical benefit brought by the new features of the Selection 9000 / Vitatron T70 DR.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sick Sinus Syndrome, Brady-Tachy Syndrome
Keywords
Pacemaker, Atrial Fibrillation, Prevention pacing, Algorithms, Sick sinus syndrome + Atrial Fibrillation

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Factorial Assignment
Masking
Single
Allocation
Randomized
Enrollment
360 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Pacemaker Vitatron Selection 9000
Intervention Type
Device
Intervention Name(s)
Pacemaker Vitatron T70
Primary Outcome Measure Information:
Title
Show clinical benefit of post-AF response and VRS algorithms, when combined versus compared with a control group: In a conventional dual chamber (DDD) configuration
Title
In a configuration including all the preventive pacing therapies of the device
Title
The primary endpoint is the atrial fibrillation burden.
Secondary Outcome Measure Information:
Title
Assess the effect of post-AF response and VRS, when combined versus compared with a control group, in a conventional DDD configuration and another configuration which includes all PPT, on: Number (Nb) of hospitalizations
Title
Nb of cardioversions
Title
Symptom score
Title
Restarts
Title
Daily incidence of AF
Title
Mean sinus rhythm duration
Title
Assess clinical benefit of the overall AF therapies, as compared with the first four algorithms of the previous device (one continuous overdrive +3 triggered overdrive), on the same outcomes as above and AF burden

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with documented atrial fibrillation: at least one episode of paroxysmal AF documented 6 months prior to inclusion, lasting more than one minute Patient with a brady-tachy syndrome or a sick sinus syndrome, with a permanent pacing indication Atrial lead with a tip-to-ring interval equal to or less than 12 mm Patient who agrees with and has signed the informed consent Exclusion Criteria: Permanent AF AF related to a reversible cause One electrical cardioversion 6 months prior to inclusion Unstable angina Myocardial infarction (MI) less than 3 months Planned cardiac surgery or performed in the last 3 months Congestive heart failure, New York Heart Association (NYHA) class IV Life expectancy less than 18 months Patient participating in other studies Patient not able to follow the FU calendar Less than 18 years of age Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christèle Pelade, Engineer
Phone
01 53 98 83 00
Email
christele.pelade@vitatron.com
First Name & Middle Initial & Last Name or Official Title & Degree
Bérangère Leroy, Engineer
Phone
01 53 98 83 00
Email
berangere.leroy@vitatron.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick Attuel, MD
Organizational Affiliation
CNOM
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHG
City
Abbeville
ZIP/Postal Code
80100
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Ernst Poulard, MD
Phone
+33 322255200
First Name & Middle Initial & Last Name & Degree
Jean-Ernst Poulard, MD
Facility Name
Hopital Privé
City
Antony
ZIP/Postal Code
92160
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Didier Gedin, MD
Phone
+33 146743700
First Name & Middle Initial & Last Name & Degree
Didier Gedin, MD
First Name & Middle Initial & Last Name & Degree
Cyrus Moini, MD
Facility Name
CH
City
Auxerre
ZIP/Postal Code
89011
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François-Xavier Soto, MD
Phone
+33 386484658
First Name & Middle Initial & Last Name & Degree
François-Xavier Soto, MD
First Name & Middle Initial & Last Name & Degree
Stéphane Mourot, MD
Facility Name
CH
City
Avignon
ZIP/Postal Code
84902
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Paul Faugier, MD
Phone
+33 432753141
First Name & Middle Initial & Last Name & Degree
Jean-Paul Faugier, MD
Facility Name
Clinique de Bordeaux Cauderan
City
Bordeaux
ZIP/Postal Code
33300
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laurent Gencel, MD
First Name & Middle Initial & Last Name & Degree
Laurent Gencel, MD
Facility Name
CHU
City
Caen
ZIP/Postal Code
14033
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrice Scanu, MD
Phone
+33 231063106
First Name & Middle Initial & Last Name & Degree
Patrice Scanu, MD
Facility Name
CH
City
Castres
ZIP/Postal Code
81108
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal Chavernac, MD
Phone
+33 563716328
First Name & Middle Initial & Last Name & Degree
Pascal Chavernac, MD
Facility Name
HIA Percy
City
Clamart
ZIP/Postal Code
92141
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Plotton, MD
Phone
+33 141466241
First Name & Middle Initial & Last Name & Degree
Christian Plotton, MD
Facility Name
CH
City
Colmar
ZIP/Postal Code
68024
Country
France
Individual Site Status
Completed
Facility Name
CH René Pleven
City
Dinan
ZIP/Postal Code
22101
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick Bazin, MD
Phone
+33 296857250
First Name & Middle Initial & Last Name & Degree
Patrick Bazin, MD
Facility Name
CH
City
Dole
ZIP/Postal Code
39108
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hugues Zimmermann, MD
Phone
+33 384798065
First Name & Middle Initial & Last Name & Degree
Hugues Zimmermann, MD
Facility Name
CH
City
Dunkerque
ZIP/Postal Code
59240
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Charles Aisenfarb, MD
Phone
+33 328285623
First Name & Middle Initial & Last Name & Degree
Jean-Charles Aisenfarb, MD
Facility Name
CH
City
Evreux
ZIP/Postal Code
27000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bouchaib Deriouich, MD
First Name & Middle Initial & Last Name & Degree
Bouchaib Deriouich, MD
Facility Name
CH
City
Grenoble
ZIP/Postal Code
38043
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal Defaye, MD
Phone
+33 476765507
First Name & Middle Initial & Last Name & Degree
Pascal Defaye, MD
Facility Name
CMC Parly II
City
Le Chesnay
ZIP/Postal Code
78150
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick Attuel, MD
Phone
+33 139637000
First Name & Middle Initial & Last Name & Degree
Patrick Attuel, MD
Facility Name
CH
City
Le Havre
ZIP/Postal Code
76083
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Isabelle Cheradame, MD
Phone
+33 232733155
First Name & Middle Initial & Last Name & Degree
Isabelle Cheradame, MD
First Name & Middle Initial & Last Name & Degree
Jean-Pierre Favier, MD
Facility Name
CH
City
Limoges
ZIP/Postal Code
87042
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christophe D'Ivernois, MD
Phone
+33 555056310
First Name & Middle Initial & Last Name & Degree
Christophe D'Ivernois, MD
Facility Name
CH Saint Philibert
City
Lomme
ZIP/Postal Code
59160
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pierre Graux, MD
Phone
+33 320225058
First Name & Middle Initial & Last Name & Degree
Pierre Graux, MD
Facility Name
Clinique de la Casamance
City
Marseille
ZIP/Postal Code
13000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacques Faure, MD
First Name & Middle Initial & Last Name & Degree
Jacques Faure, MD
Facility Name
Clinique Bouchard
City
Marseille
ZIP/Postal Code
13006
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maxime Guenoun, MD
Phone
+33 491159062
First Name & Middle Initial & Last Name & Degree
Maxime Guenoun, MD
First Name & Middle Initial & Last Name & Degree
Olivier Roux, MD
Facility Name
CHU La Timone
City
Marseille
ZIP/Postal Code
13385
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Claude Deharo, Pr
Phone
+33 491386575
First Name & Middle Initial & Last Name & Degree
Jean-Claude Deharo, Pr
Facility Name
CH
City
Martigues
ZIP/Postal Code
136995
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
André Ebagosti, MD
Phone
+33 442432540
First Name & Middle Initial & Last Name & Degree
André Ebagosti, MD
Facility Name
CH
City
Metz
ZIP/Postal Code
57000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michel Boursier, MD
Phone
+33 387553231
First Name & Middle Initial & Last Name & Degree
Michel Boursier, MD
Facility Name
CHU
City
Montpellier
ZIP/Postal Code
34295
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Marc Davy, Pr
Phone
+33 467336164
First Name & Middle Initial & Last Name & Degree
Jean-Marc Davy, Pr
First Name & Middle Initial & Last Name & Degree
Jean-Luc Pasquié, MD
First Name & Middle Initial & Last Name & Degree
Franck Raczka, MD
Facility Name
CH
City
Mulhouse
ZIP/Postal Code
68051
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacques Levy, MD
Phone
+33 389647120
First Name & Middle Initial & Last Name & Degree
Jacques Levy, MD
Facility Name
Clinique Ambroise Paré
City
Neuilly sur Seine
ZIP/Postal Code
92200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier Thomas, MD
Phone
+33 146418965
First Name & Middle Initial & Last Name & Degree
Olivier Thomas, MD
Facility Name
Hopital Cardiologique du Haut Leveque
City
Pessac
ZIP/Postal Code
33604
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacques Clementy, Pr
Phone
+33 557656471
First Name & Middle Initial & Last Name & Degree
Jacques Clementy, Pr
First Name & Middle Initial & Last Name & Degree
Sylvain Reuter, MD
Facility Name
Hopital Privé Claude Galien
City
Quincy-sous-Sénart
ZIP/Postal Code
91480
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dominique Bleinc, MD
Phone
+33 169399132
First Name & Middle Initial & Last Name & Degree
Dominique Bleinc, MD
Facility Name
Polyclinique Saint Laurent
City
Rennes
ZIP/Postal Code
35000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Michel Baisset, MD
First Name & Middle Initial & Last Name & Degree
Jean-Michel Baisset, MD
Facility Name
CHU
City
Rennes
ZIP/Postal Code
35033
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe Mabo, Pr
Phone
+33 299282527
First Name & Middle Initial & Last Name & Degree
Philippe Mabo, Pr
Facility Name
CHU
City
Rouen
ZIP/Postal Code
76035
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Frédéric Anselme, MD
Phone
+33 232888111
First Name & Middle Initial & Last Name & Degree
Frédéric Anselme, MD
First Name & Middle Initial & Last Name & Degree
Arnaud Savoure, MD
Facility Name
CHU
City
Saint Etienne
ZIP/Postal Code
42055
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antoine Da Costa, MD
Phone
+33 477828340
First Name & Middle Initial & Last Name & Degree
Antoine Da Costa, MD
Facility Name
Institut Arnalt Tzanck
City
Saint Laurent du Var
ZIP/Postal Code
06721
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Claude Mariottini, MD
Phone
++33 4 92 27 37 27
First Name & Middle Initial & Last Name & Degree
Claude Mariottini, MD
First Name & Middle Initial & Last Name & Degree
Philippe Durand, MD
Facility Name
CMCO
City
Schiltigheim
ZIP/Postal Code
67303
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François Philippot, MD
Phone
+33 3 88628318
First Name & Middle Initial & Last Name & Degree
François Philippot, MD
Facility Name
CH
City
Thionville
ZIP/Postal Code
57100
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Yves Thisse, MD
Phone
+33 382558300
First Name & Middle Initial & Last Name & Degree
Jean-Yves Thisse, MD
First Name & Middle Initial & Last Name & Degree
Philippe Houplon, MD
Facility Name
CH Toulon
City
Toulon
ZIP/Postal Code
83056
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Isabelle Canavy, MD
Phone
+33 494616069
First Name & Middle Initial & Last Name & Degree
Isabelle Canavy, MD
First Name & Middle Initial & Last Name & Degree
Alex Baralla, MD
First Name & Middle Initial & Last Name & Degree
Jean Julienne, MD
Facility Name
CH
City
Valenciennes
ZIP/Postal Code
59322
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Benaissa Agraou, MD
Phone
+33 327143041
First Name & Middle Initial & Last Name & Degree
Benaissa Agraou, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
12687819
Citation
Fauchier L, Briand F, Soto FX, Quennelle F, Levy J, Darmon JP, Lellouche D, Lavergne T, Poret P, Pelade C, Babuty D. Management of atrial tachyarrhythmias: benefits of pacemaker diagnostics. Pacing Clin Electrophysiol. 2003 Jan;26(1P2):233-8. doi: 10.1046/j.1460-9592.2003.00023.x.
Results Reference
background
Citation
Camm AJ on behalf of the AFTherapy Study Group. The Atrial Fibrillation Therapy Study. Présentation orale au cours du Congrès de l'ESC à Stockholm, Septembre 2001.
Results Reference
background
PubMed Identifier
11601835
Citation
Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG; American College of Cardiology; American Heart Association; European Society of Cardiology; North American Society of Pacing and Electrophysiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001 Oct;22(20):1852-923. doi: 10.1053/euhj.2001.2983. No abstract available.
Results Reference
background
PubMed Identifier
10455082
Citation
Tse HF, Lau CP, Ayers GM. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart. 1999 Sep;82(3):319-24. doi: 10.1136/hrt.82.3.319.
Results Reference
background
PubMed Identifier
12466514
Citation
Falk RH. Management of atrial fibrillation--radical reform or modest modification? N Engl J Med. 2002 Dec 5;347(23):1883-4. doi: 10.1056/NEJMe020137. No abstract available.
Results Reference
background
PubMed Identifier
12466507
Citation
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002 Dec 5;347(23):1834-40. doi: 10.1056/NEJMoa021375.
Results Reference
background
PubMed Identifier
12466506
Citation
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002 Dec 5;347(23):1825-33. doi: 10.1056/NEJMoa021328.
Results Reference
background
PubMed Identifier
11117910
Citation
Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000 Nov 25;356(9244):1789-94. doi: 10.1016/s0140-6736(00)03230-x.
Results Reference
background
PubMed Identifier
11350085
Citation
Hohnloser SH, Kuck KH. Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J. 2001 May;22(10):801-2. doi: 10.1053/euhj.2001.2596. No abstract available.
Results Reference
background
PubMed Identifier
9725923
Citation
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998 Sep 3;339(10):659-66. doi: 10.1056/NEJM199809033391003.
Results Reference
background
PubMed Identifier
9474682
Citation
Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol. 1998 Jan;21(1 Pt 2):250-5. doi: 10.1111/j.1540-8159.1998.tb01098.x.
Results Reference
background
PubMed Identifier
9652562
Citation
Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25;350(9086):1210-6. doi: 10.1016/S0140-6736(97)03425-9.
Results Reference
background
PubMed Identifier
10805823
Citation
Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000 May 11;342(19):1385-91. doi: 10.1056/NEJM200005113421902.
Results Reference
background
PubMed Identifier
10942740
Citation
Gillis AM, Connolly SJ, Lacombe P, Philippon F, Dubuc M, Kerr CR, Yee R, Rose MS, Newman D, Kavanagh KM, Gardner MJ, Kus T, Wyse DG. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation. 2000 Aug 15;102(7):736-41. doi: 10.1161/01.cir.102.7.736.
Results Reference
background
Citation
Edvardson N. Efficacy of preventive pacing therapies in Paroxysmal Atrial Fibrillation - IV International meeting - Atrial Fibrillation 2001 : 161-164.
Results Reference
background
Citation
Hoffmann E, Janko S, Steinbeck G and al. Onset scenarios of paroxysmal atrial fibrillation using new diagnostic pacemaker functions. Pacing Clin Electrophysiol. 2000 ; 23(4) : 656 (abstract).
Results Reference
background
Citation
Hoffmann E, Janko S, Steinbeck G and al. Analysis of Onset Mechanisms of Paroxysmal Atrial Fibrillation through a Pacemaker with Continuous Monitoring Capabilities. Pacing Clin Electrophysiol. 2000 ; 23(4) : 656 (poster).
Results Reference
background
Citation
Capucci A, Gropppi F, Ruiter J on behalf of the AFTherapy Study Group. Re-initiation of atrial Fibrillation Investigated Through pacemaker Focussed Diagnostics. Europace 2000 - Supplement 1.
Results Reference
background
PubMed Identifier
10924300
Citation
Tse HF, Lau CP, Ayers GM. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion. Eur Heart J. 2000 Jul;21(14):1167-76. doi: 10.1053/euhj.1999.1991.
Results Reference
background
PubMed Identifier
10234708
Citation
Lee JK, Yee R, Braney M, Stoop G, Begemann M, Dunne C, Klein GJ, Krahn AD, Van Hemel NM. Acute testing of the rate-smoothed pacing algorithm for ventricular rate stabilization. Pacing Clin Electrophysiol. 1999 Apr;22(4 Pt 1):554-61. doi: 10.1111/j.1540-8159.1999.tb00496.x.
Results Reference
background
PubMed Identifier
9558685
Citation
Lau CP, Jiang ZY, Tang MO. Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fibrillation. Pacing Clin Electrophysiol. 1998 Mar;21(3):542-8. doi: 10.1111/j.1540-8159.1998.tb00096.x.
Results Reference
background
PubMed Identifier
8970422
Citation
Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol. 1996 Dec 15;78(12):1433-6. doi: 10.1016/s0002-9149(97)89297-1.
Results Reference
background
Citation
Yee R, Meijer A and Winkler WB and al. Effect of Chronic Ventricular Rate Stabilization on Rate Irregularity in Patients with Permanent Atrial Fibrillation. Progress in Clinical Pacing - Rome 2002 : 52 (abstract)
Results Reference
background
Citation
Pfaiffer L, Canby P, Navone A and al. Impact of Atrial Rhythm Diagnostics on Clinical Management. Europace Supplements 2002 ; 3 : A 152 (abstract).
Results Reference
background
PubMed Identifier
12427427
Citation
Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002 Nov 6;40(9):1703-19. doi: 10.1016/s0735-1097(02)02528-7. No abstract available.
Results Reference
background
PubMed Identifier
8950060
Citation
Jenkins LS, Bubien RS. Quality of life in patients with atrial fibrillation. Cardiol Clin. 1996 Nov;14(4):597-606. doi: 10.1016/s0733-8651(05)70307-6.
Results Reference
background
Citation
Carlioz R, Perrier E, Thomas O and al. Accuracy of atrial Tachyarrhythmia Monitoring in the Selection Device : Correlation with an External Holter Recording. Europace Suppl 2001 ; 2 : B199.
Results Reference
background
Citation
Jenkins LS. Quality of life in Patients with Atrial Fibrillation. Circulation 1995 ; 92 (I) : 490 (abstract).
Results Reference
background
PubMed Identifier
8840848
Citation
Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996 Oct 1;94(7):1585-91. doi: 10.1161/01.cir.94.7.1585.
Results Reference
background

Learn more about this trial

Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation

We'll reach out to this number within 24 hrs